New Brunswick, NJ, United States of America

Eddy Arnold


Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Eddy Arnold: Innovator in Antiviral Compounds

Introduction

Eddy Arnold is a notable inventor based in New Brunswick, NJ (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of five patents, focusing on compounds with significant antiviral properties. His work has the potential to impact therapeutic approaches in medicine.

Latest Patents

Eddy Arnold's latest patents include innovative compounds such as therapeutic hydroxypyridinones, hydroxypyrimidinones, and hydroxypyridazinones. These inventions provide compounds of formula I and salts and prodrugs thereof, wherein R, X, and X have specific meanings defined in the specification. The pharmaceutical compositions comprising these compounds are designed for therapeutic use, showcasing their useful antiviral properties. Additionally, he has developed therapeutic hydroxyquinolones, which also include compounds of formula (I) and salts thereof, further emphasizing their potential in antiviral therapy.

Career Highlights

Eddy Arnold is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research and innovation in the pharmaceutical field. His work is characterized by a commitment to developing effective antiviral treatments that can benefit public health.

Collaborations

Eddy Arnold has collaborated with notable colleagues such as Joseph David Bauman and Kalyan Das, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Eddy Arnold's contributions to antiviral compounds through his patents reflect his dedication to advancing medical science. His work at Rutgers University positions him as a key figure in the ongoing fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…